China Universal Asset Management Co., Ltd. Mirum Pharmaceuticals, Inc. Call Options Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MIRM
# of Institutions
227Shares Held
55.4MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$350 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$245 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$167 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$144 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$131 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.89B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...